The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3549-3558

  Sauty, Alain ^a   Dziejman, Michelle ^a   Taha, Rame A ^b   Iarossi, Albert S ^a   Neote, Kuldeep ^c   Garcia Zepeda, Eduardo A ^a   Hamid, Qutayba ^b   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HLA SYSTEM; HOST RESISTANCE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LUNG LAVAGE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESPIRATORY EPITHELIUM; RNA ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

BRONCHI; CELL LINE; CELL LINE, TRANSFORMED; CELL-FREE SYSTEM; CHEMOKINES, CXC; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITHELIAL CELLS; HUMANS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; KINETICS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; T-LYMPHOCYTES; TH2 CELLS;

EID: 0033559522     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
2. Taha, R. A., T. C. Kotsimbos, Y. L. Song, D. Menzies, and Q. Hamid. 1997. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis. Am. J. Respir. Crit. Care Med. 155:1135.
3. Edwards, D., and C. H. Kirkpatrick. 1986. The immunology of mycobacterial diseases. Am. Rev. Respir. Dis. 134:1062.
4. Barnes, P. F., A. B. Bloch, P. T. Davidson, and J. D. D. Snider. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644.
5. Horsburgh, C. R. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332.
6. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte eMigration: the multiple paradigm. Cell 76:301.
7. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
8. Thompson, A. B., R. A. Robbins, D. J. Romberger, J. H. Sisson, J. R. Spurzem, H. Teschler, and S. I. Rennard. 1995. Immunological functions of the pulmonary epithelium. Eur. Respir. J. 8:127.
9. Bloemen, P. G. M., M. C. v. d. Tweel, P. A. J. Henricks, F. Engels, S. S. Wagenaar, A. A. J. J. L. Rutten, and F. P. Nijkamp. 1993. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:586.
10. Atsuta, J., S. A. Sterbinsky, J. Plitt, L. M. Schwiebert, B. S. Bochner, and R. P. Schleimer. 1997. Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am. J. Respir. Cell Mol. Biol. 17: 571.
11. Rossi, G. A., O. Sacco, B. Balbi, S. Oddera, T. Mattioni, G. Corte, C. Ravazzoni, and L. Allegra. 1990. Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR α gene, modulation of HLA-DR antigens by γ-interferon and antigen-presenting function in the mixed leukocyte reaction. Am. J. Respir. Cell Mol. Biol. 3:431.
12. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
13. Clark-Lewis, I., B. Dewald, T. Geiser, B. Moser, and M. Baggiolini. 1993. Platelet factor 4 binds to interleukin-8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA 90:3574.
14. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
15. Loetscher, M., B. Gerber, P. Loestcher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963.
16. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182:1301.
17. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
18. Cole, K. E., C. A. Strick, M. Loetscher, T. J. Paradis, K. T. Ogborne, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, B. G. Sahagan, and K. Neote. 1998. Interferon inducible T-cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T-cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009.
19. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101.
20. D'Apuzzo, M., A. Rolink, M. Loetscher, J. A. Hoxie, I. Clark-Lewis, F. Melchers, M. Baggiolini, and B. Moser. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1788.
21. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187: 655.
22. Sousa, A. R., S. J. Lane, J. A. Nakhosteen, T. Yoshimura, T. H. Lee, and R. N. Poston. 1994. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 10:142.
23. Humbert, M., S. Ying, C. Corrigan, G. Menz, J. Barkans, R. Pfister, Q. Meng, J. V. Damme, G. Opdenakker, S. R. Durham, and A. B. Kay. 1997. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 16:1.
24. Garcia-Zepeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613.
25. Stellato, C., P. Collins, P. D. Ponath, D. Soler, W. Newman, G. L. Rosa, H. Li, J. White, L. M. Schwiebert, C. Bickel, et al. 1997. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99:926.
26. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, M. E. Rothenberg, E. A. Garcia-Zepeda, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767.
27. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
28. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch III, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945.
29. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Streiter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174:1355.
30. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672.
31. Ransohoff, R. M., T. A. Hamilton, M. Tani, M. H. Stoler, H. E. Shick, J. A. Major, M. L. Estes, D. M. Thomas, and V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592.
32. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084.
33. Cassatella, M. A., S. Gasperini, F. Calzelti, A. Bertagnin, A. D. Luster, and P. P. McDonald. 1997. Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27:111.
34. Farber, J. M. 1990. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA 87:5238.
35. Gottlieb, A. B., A. D. Luster, D. N. Posnett, and D. M. Carter. 1988. Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168: 941.
36. Kaplan, G., A. D. Luster, G. Hancock, and Z. A. Cohn. 1987. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166:1098.
37. Agostini, C., M. Cassatella, R. Sancetta, R. Zambello, L. Trentin, S. Gasperini, A. Perin, F. Piazza, M. Siviero, A. D. Luster, et al. 1998. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J. Immunol. 161:6413.
38. Lahrtz, F., L. Piali, D. Nadal, H. W. Pfister, K. S. Spanaus, M. Baggiolini, and A. Fontana. 1998. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-γ-inducible protein-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 10:2484.
39. Gómez-Chiarri, M., A. Ortiz, S. González-Cuadrado, D. Seron, S. N. Emancipator, T. A. Hamilton, A. Barat, J. J. Plaza, E. Gonzáles, and J. Egido. 1996. Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis. Am. J. Pathol. 148:301.
40. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746.
41. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
42. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344.
43. Bonecchi, R., G. Bianchi, P. Panina-Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of Th1 and Th2 cells. J. Exp. Med.
44. Luster, A. D., S. M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:219.
45. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffrey, et al. 1991. Expression of mRNA for IL-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87: 1541.
46. Lamer, A. C., E. F. Petricoin, Y. Nakagawa, and D. S. Finbloom. 1993. IL-4 attenuates the transcriptional activation of both IFN-α- and IFN-γ-induced cellular gene expression in monocytes and monocytic cell lines. J. Immunol. 150-1944.
47. Deng, W., Y. Ohmori, and T. A. Hamilton. 1994. Mechanisms of IL-4-mediated suppression of IP-10 gene expression in murine macrophages. J. Immunol. 153: 2130.
48. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and R. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J. Immunol. 155:410.
49. Boorsma, D. M., P. d. Haan, R. Willemze, and T. J. Stoof. 1994. Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-γ-inducible protein (γ-IP-10) gene expression in cultured normal human keratinocytes. Arch. Dermatol. Res. 286:471.
50. Bloom, J. W. 1997. Molecular pharmacology of glucocorticoids. Clin. Asthma Rev. 1:99.
51. Kwon, O. J., B. T. Au, P. D. Collins, J. N. Baraniuk, I. M. Adcock, K. F. Chung, and P. J. Barnes. 1994. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 81:389.
52. Mukaida, N., C. C. Zachariae, G. L. Gusella, and K. M. K. 1991. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol. 146:1212.
53. Strieter, R. M., S. L. Kunkel, D. A. Arenberg, M. D. Burdick, and P. J. Polverini. 1995. Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210:5 1.
54. Angiolillo, A. L., C. Sgadari, D. D. Taub, F. Liao, J. M. Farber, S. Maheshwari, H. K. Kleinmann, G. H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155.
55. Sgadari, C., A. L. Angiolillo, and G. Tosato. 1996. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87:3877.
56. Sgadari, C., J. M. Farber, A. L. Angiolillo, F. Liao, J. Teruya-Feldstein, P. R. Burd, L. Yao, G. Gupta, C. Kanegane, and G. Tosato 1997. Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo. Blood 1997: 2635.
57. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798.
58. Keane, M. P., D. A. Arenberg, J. P. Lynch III, R. I. Whyte, M. D. Iannettoni, M. D. Burdick, C. A. Wilke, S. B. Morris, M. C. Glaas, B. DiGiovine, et al. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenetic activity in idiopathic pulmonary fibrosis. J. Immunol. 159:1437.
59. Piguet, P. F., C. Ribaux, V. Karpuz, G. E. Grau, and Y. Kapanci. 1993. Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143:651.
60. Kapanci, Y., A. Desmouliere, J. C. Pache, M. Redard, and G. Gabbiani. 1995. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis: possible role of transforming growth factor β and tumor necrosis factor α. Am. J. Respir. Cell Mol. Biol. 152:2163.
61. Zhang, Y., T. C. Lee, B. Guillemin, M. C. Yu, and W. N. Rom. 1993. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150:4188.
62. Smoller, B. R., A. D. Luster, J. F. Krane, J. Krueger, M. H. Gray, N. S. McNutt, A. Hsu, and A. B. Gottlieb. 1991. Fixed drug eruptions: evidence for a cytokine-mediated process. J. Cutan. Pathol. 18:13.
63. + lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood 86:651.
64. Saed, G., D. P. Fiveson, Y. Naidu, and B. J. Nickoloff. 1994. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile, whereas Sezary syndrome expresses a Th2 profile. J. Invest. Dermatol. 103:29.
65. Grimm, M. C., and W. F. Doe. 1996. Chemokines in inflammatory bowel disease mucosa: expression of RANTES, macrophage inflammatory protein (MIP)-1α, MIP-1β, and γ-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas. Inflammatory Bowel Dis. 2:88.
66. Gangur, V., F. E. R. Simons, and K. T. Hayglass. 1998. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFNγ over IL-4 responses. FASEB J 12:705.